# A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection

> **NCT01473836** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 38 (actual)

## Conditions studied

- Intra-abdominal Infections

## Interventions

- **DRUG:** Metronidazole
- **DRUG:** Ceftriaxone sodium

## Key facts

- **NCT ID:** NCT01473836
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2014-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01473836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01473836, "A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01473836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*